Free Trial
→ Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (From Colonial Metals) (Ad) Free HIMS Stock Alerts

Hims & Hers Health (HIMS) Stock Forecast & Price Target

Hims & Hers Health logo
$26.70 -1.18 (-4.23%)
(As of 11/12/2024 ET)
Compare

Hims & Hers Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 16 Analyst Ratings
Sell
0
Hold
8
Buy
8

Based on 16 Wall Street analysts who have issued ratings for Hims & Hers Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 8 have given a hold rating, and 8 have given a buy rating for HIMS.

Consensus Price Target

$21.21
-20.55% Downside
According to the 16 analysts' twelve-month price targets for Hims & Hers Health, the average price target is $21.21. The highest price target for HIMS is $28.00, while the lowest price target for HIMS is $10.00. The average price target represents a forecasted downside of -20.55% from the current price of $26.70.

HIMS Analyst Ratings Over Time

TypeCurrent Forecast
11/14/23 to 11/13/24		1 Month Ago
10/15/23 to 10/14/24		3 Months Ago
8/16/23 to 8/15/24		1 Year Ago
11/14/22 to 11/14/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$21.21$20.07$20.00$12.36
Forecasted Upside-20.55% Downside-2.04% Downside27.27% Upside67.98% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Moderate Buy

HIMS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HIMS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Hims & Hers Health Stock vs. The Competition

TypeHims & Hers HealthMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.80
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside-20.55% Downside25,508.19% Upside7.92% Upside
News Sentiment Rating
Positive News

See Recent HIMS News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/8/2024TD Cowen
4 of 5 stars		 Boost TargetBuy ➝ Buy$25.00 ➝ $28.00+25.17%
11/6/2024Deutsche Bank Aktiengesellschaft
3 of 5 stars		 Boost TargetHold ➝ Hold$23.00 ➝ $27.00+12.17%
11/5/2024Piper Sandler
2 of 5 stars		 Reiterated RatingNeutral ➝ Neutral$18.00 ➝ $21.00-3.14%
11/5/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$24.00 ➝ $28.00+34.87%
10/21/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$23.00 ➝ $25.00+12.87%
8/22/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		R. Macdonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageBuy$24.00+44.93%
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here
8/9/2024Imperial Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Piccolo
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ In-Line
7/18/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHold ➝ Hold$13.00 ➝ $23.00+2.68%
6/27/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHold ➝ Hold$14.00 ➝ $23.00+19.98%
5/22/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Neutral$16.00 ➝ $20.00+13.96%
4/26/2024Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating		A. Kessler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy
2/27/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$15.00 ➝ $17.00+22.83%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingMarket Perform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform$10.00+5.04%
1/5/2024Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$14.00 ➝ $15.00+81.38%
8/8/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Outperform$14.00+77.22%
4/11/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$10.00+2.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:14 AM ET.


HIMS Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Hims & Hers Health is $21.21, with a high forecast of $28.00 and a low forecast of $10.00.

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last twelve months. There are currently 8 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HIMS shares.

According to analysts, Hims & Hers Health's stock has a predicted downside of -20.55% based on their 12-month stock forecasts.

Hims & Hers Health has been rated by research analysts at Bank of America, Canaccord Genuity Group, Deutsche Bank Aktiengesellschaft, Needham & Company LLC, Piper Sandler, and TD Cowen in the past 90 days.

Analysts like Hims & Hers Health less than other "medical" companies. The consensus rating score for Hims & Hers Health is 2.50 while the average consensus rating score for "medical" companies is 2.80. Learn more on how HIMS compares to other companies.

Related Companies
Today's Ratings
Top Rated Stocks
More Ratings Tools

This page (NYSE:HIMS) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...
Colonial Metals | Sponsored
You just voted for a financial crisis
I’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...
Porter & Company | Sponsored
24/7 Automated Profits in Crypto
The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...
Crypto Swap Profits | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored